A history of blood cancer treatment
pharmaphorum
SEPTEMBER 13, 2022
The following year, the regulator also approved Rituximab, a monoclonal antibody targeting CD-20 positive B-cells, as a companion treatment of chemotherapy in older diffuse large B-cell lymphoma patients. 2012 – The 100,000 Genomics Project begins. 2002 – Emergence of CAR-T therapy.
98 
Let's personalize your content